Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Dec 1;43(12):1156-1161.
doi: 10.1097/INF.0000000000004459. Epub 2024 Jun 26.

Acyclovir Dosing Practices Across a Multicenter Cohort of Neonatal Intensive Care Units

Henry P Foote  1 , Haley Thomassy  1   2 , Leonardo Baquero  1   2 , Mina Cayli  1   2 , Elijah Jacobs  1   2 , Anish Paladugu  1   2 , Anisha Roy  1   2 , Elizabeth Heyward  1 , Reese H Clark  3 , Christoph P Hornik  1   4 , Daniel K Benjamin  5 , Daniel K Benjamin Jr  1   4 , Rachel G Greenberg  1   4
Affiliations
Multicenter Study

Acyclovir Dosing Practices Across a Multicenter Cohort of Neonatal Intensive Care Units

Henry P Foote et al. Pediatr Infect Dis J. .

Abstract

Background: Acyclovir is the first-line therapy for neonatal herpes simplex virus infections. Therapy can mitigate morbidity and mortality but carries a risk for toxicity. We aimed to compare acyclovir dosing in neonatal intensive care units to published recommendations based on population pharmacokinetic (PopPK) analysis.

Methods: We performed a multicenter cohort study of infants in neonatal intensive care units managed by the Pediatrix Medical Group from 1997 to 2020. We included all infants who received acyclovir with complete dosing information. Our primary outcome was the proportion of courses with dosing within 80%-120% of the PopPK recommended daily dose and at the recommended dosing frequency. We compared dosing before and after the publication of the 2014 PopPK recommendations using linear probability modeling.

Results: We identified 6862 infants with complete dosing information across 308 centers. Dosing met PopPK recommendations for 41% of treatment courses for infants <30 weeks postmenstrual age (PMA), 71% for infants 30 to <36 weeks PMA and <1% for infants ≥ 36 weeks PMA. Comparison of dosing from 1997 to 2013 with that from 2015 to 2020 showed a significant increase in dosing meeting PopPK recommendations for infants <30 weeks PMA ( P = 0.008) and infants 30 to <36 weeks PMA ( P = 0.02) but not infants ≥ 36 weeks PMA ( P = 0.29). No significant increase in dosing meeting PopPK recommendations was seen for any PMA group when comparison was limited to more recent years (2008-2013 vs. 2015-2020).

Conclusions: Dosing meeting PopPK recommendations increased over time for some PMA groups, but dosing different than PopPK recommendations remains common. More research is needed to clarify optimal dosing strategies in these infants.

Keywords: acyclovir; infants; neonatal herpes; neonatal intensive care unit; population pharmacokinetic.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Proportion of infants with dosing meeting recommendations based on PopPK analysis, by PMA group. PopPK analysis published in 2014. PMA indicates postmenstrual age. PopPK, population pharmacokinetic.
Figure 2:
Figure 2:
Total daily dosing by PMA group as a percentage of recommended daily dosing based on PopPK analysis for years 2015–2020. PMA indicates postmenstrual age; PopPK, population pharmacokinetic.
See this image and copyright information in PMC

References

    1. Kimberlin DW, Lin C, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108(2):223–229. - PubMed
    1. Shah SS, Aronson PL, Mohamad Z, Lorch SA. Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Pediatrics. Dec 2011;128(6):1153–1160. doi: 10.1542/peds.2011-0177 - DOI - PMC - PubMed
    1. Schreiber R, Wolpin J, Koren G. Determinants of aciclovir-induced nephrotoxicity in children. Pediatr Drugs. 2008;10(2):135–139. - PubMed
    1. Zoviroax (acyclovir sodium) for injection. Package insert. DSM Pharmaceuticals, Inc. 2003.
    1. Kimberlin DW, Lin C, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230–238. - PubMed

Publication types

MeSH terms

Supplementary concepts